Editas Medicine Names James C. Mullen as Chairman of the Board … – GlobeNewswire (press release)
|
Editas Medicine Names James C. Mullen as Chairman of the Board …
GlobeNewswire (press release) CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the appointment of James C. Mullen as Chairman of the Board of Directors, effective immediately. Mr. Mullen has … |
